Bruno Silva will have to wait until at least 2021 before he can make his UFC debut.
On Monday, the United States Anti-Doping Agency announced that the Brazilian fighter would face a two-year suspension after he tested positive for “boldenone and its metabolite, 5β-androst-1-en-17β-hydroxy-3-one, at a level inconsistent with boldenone meat contamination as the result of a urine sample collected out-of-competition on May 27, 2019.”
Boldenone is an anabolic steroid and numerous fighters have tested positive for the drug in the past.
Silva was originally scheduled to compete last June in a middleweight fight against Deron Winn, but he was pulled from the bout due to the results of his drug test.